| Literature DB >> 23282380 |
Ayşe Baççoğlu Kavut1, A Füsun Kalpakloğlu.
Abstract
BACKGROUND: : The asthma control test (ACT) is a reliable tool to measure the level of asthma control. In our research, we aimed to investigate the effect of participation in an asthma awareness session on the patient's perception of current asthma control as evaluated by ACT in relation to quality of life (QoL) in an adult population.Entities:
Year: 2010 PMID: 23282380 PMCID: PMC3651062 DOI: 10.1097/WOX.0b013e3181c82002
Source DB: PubMed Journal: World Allergy Organ J ISSN: 1939-4551 Impact factor: 4.084
Demographic and Clinical Data of the Patients
| N (%) | All Patients (n:44) |
|---|---|
| Age* | 41.2 ± 13.8 |
| Female/male | 33 (75)/11 (25) |
| Education level; (year)* | 7 ± 3.5 |
| Low educated | 25 (56.8) |
| Moderate-high educated | 19 (43.2) |
| Current smokers | 7 (15.9) |
| Duration of asthma (year)* | 8.9 ± 3.5 |
| Severity of asthma | |
| Mild persistent | 19 (43.2) |
| Moderate-severe persistent | 25 (56.8) |
| Asthma exacerbation frequency (/yr)* | 2.1 ± 1.9 |
| Hospitalisation frequency (/yr)* | 0.6 ± 1.0 |
| Asthma comorbidity | |
| Obesity | 23 (52.2) |
| Drug allergy | 5 (11.4) |
| Gastro esophageal reflux | 5 (11.4) |
| Sinusitis | 26 (59.1) |
| Rhinitis | 29 (54.5) |
| Atopy | 14 (31.8) |
| FEV1%* | 84 ± 14.5 |
| Asthma management | |
| LTRA | 23 (52.2) |
| Inhaled steroid | 40 (91) |
| Nasal steroid | 18 (40.9) |
| Long-short acting β2 agonist | 35 (79.5) |
| Specific immunotherapy | 3 (6.8) |
| Total IgE (kU/l)* | 350 ± 317 |
*Mean ± SD.
ACT, Asthma control test; FEV1, Forced expiratory volume at 1st second; IgE, Immunoglobulin LTRA; Leukotriene receptor antagonist.
The Effect of the Education on ACT Scores and How They Changed, as Well as the Quality of Life Assed by SF-36 (Uncontrolled ACT is < 20)
| N (%) | All (n:44) | ACTimproved (n:17) | ACTunchanged (n:13) | ACTdeteriorated (n:14) | |
|---|---|---|---|---|---|
| ACTbefore* | 18.1 ± 4.2 | 17.6 ± 3.8 | 18.6 ± 4.1 | 18.1 ± 5.1 | 0.80 |
| Uncontrolled ACTbefore | 24 (54.5) | 10 (58.8) | 6 (46.2) | 8 (57.1) | 0.76 |
| Controlled ACTbefore | 20 (45.5) | 7 (41.2) | 7 (53.8) | 6 (42.9) | 0.76 |
| ACTafter* | 17.6 ± 4.9 | 19.7 ± 3.6 | 18.6 ± 4.1 | 14.2 ± 5.6 | 0.02 |
| Uncontrolled ACTafter | 25 (56.8) | 8 (47.1) | 6 (46.2) | 11 (78.6) | 0.13 |
| Controlled ACTafter | 19 (43.2) | 9 (52.9) | 7 (53.8) | 3 (21.4) | 0.13 |
| Mean changes in scores* | 0.5 ± 0.7 | 2.1 ± 1.3 | -- | -3.8 ± 2.7 | 0.001 |
| SF-36 scores* | |||||
| Physical CS | 59.7 ± 23.2 | 52.5 ± 27.3 | 62.1 ± 25.1 | 65.9 ± 16.1 | 0.51 |
| Mental CS | 68.4 ± 51.1 | 47.9 ± 28.5 | 68.8 ± 22.2 | 80.8 ± 76.1 | 0.14 |
*Mean ± SD.
ACT, Asthma Control Test; CS, Component summary; SF-36, Short Form Health Survey with 36-item.